Stabilization of interferon alpha-2b in a topical cream

Pharmaceutical Technology

Volumn 33, Issue 7, 2009, Pages 80-85

  Kumar, Praveen ^a   Batta, Ravinderjit ^a   La Bine, Geriene ^a   Shen, Jinghui ^a   Gaspar, Kim ^a   Docherty, John ^a   Foldvari, Marianna ^b  

^a Helix BioPharma Corp   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG MOLECULES; FORMULATION OPTIMIZATION; PROTEIN FORMULATION;

ANTIBIOTICS; GLYCOPROTEINS;

PROTEINS;

ALPHA2A INTERFERON; ALPHA2B INTERFERON; ALPHAN3 INTERFERON; BECAPLERMIN; BETA1A INTERFERON; CONSENSUS INTERFERON; GAMMA1B INTERFERON; INTERFERON BETA SERINE; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG STABILITY; FOLLICULAR LYMPHOMA; HAIRY CELL LEUKEMIA; HEPATITIS B; HEPATITIS C; HUMAN; KAPOSI SARCOMA; MELANOMA; MICROENCAPSULATION; NONHUMAN; REVIEW;

EID: 77951605443     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. "Interferon-a" in Human Cytokines: Handbook for Basic and Clinical Research, B.B. Agganval, and J.U. Giuimnan, Eds. (Black well Scientific Publications, Cambridge, MA, 1992), pp. 13-15.
2. C.E, Samuel,"Antiviral Aclionsof Interferons," Clin. Microbiol. Rev, 14 H), 778-809(2001).
3. RGrelliandK. Tyring, "Interferons in Human Papillomavirus Infections," Antiviral Res. 24 (2-3), 191-204 (1994).
4. MJ. King el al., "Transdermal Delivery of Insulin from a Novel Bi-pliasic Lipid System in Diabetic Rats," Diabetes Technol. Ther. 4 {4), 479-488 (2002).
5. M. Foldvari et al., "Biphasic Vesicles as a Topical Delivery System for Interferon Alpha," submitted for publication
6. M. Cindric et al., "Evaluation of Recombinant Human Interferon a-2b Structure and Stability by In-gel Tryptic Digest ion, H/D Exchange and Mass Spectroscopy,"/Pharm. Biomed. Anal. 40 (3), 781-787 (2006).
7. G. Giltlin el al., "Isolalion and Characterization of a MonomeThi-oninesulfbxide Variant of Interferon a-2b," Pharm. Res. 13 (5), 762-769 (1-96)
8. S, K.H. Buchheit, A. Daas, andK.H. lonsson, "Collaborative Study for Establishment of an HPLC Method for Batch Consistency Control of Recombinant Interferon-alfa-2," PharmeuropaSpec, Issue Biol. 2002 (1), 7-21 (2002).
9. K.I. Gasparet al, "In Vitro Absorption of Interferon Alpha-2b From a Topical Biphasix Formulation," manuscript in preparation. f-T